Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX 4 vs 5-FU/Cisplatin in Inoperable Esophageal Cancer
NCT00160030Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Primary completion
- Oct 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in esophageal cancer, sponsored by Sanofi. Started Sep 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00160030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160030.